கீமோ மரபியல் ஆராய்ச்சி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கீமோ மரபியல் ஆராய்ச்சி நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கீமோ மரபியல் ஆராய்ச்சி நிறுவனம் Today - Breaking & Trending Today

COVID-19 vaccination: Africa in danger of being left behind – WHO

COVID-19 vaccination: Africa in danger of being left behind – WHO
Published
The World Health Organisation (WHO) has warned that Africa is in danger of being left behind in COVID-19 vaccination as prices spike due to competition in other regions.
NAN reports that the agency’s Regional Director for Africa, Dr Matshidiso Moeti, gave the warning during a briefing on Thursday.
Moeti stated that Guinea was the only low-income country on the continent to have received doses, with only 25 people vaccinated so far.
According to her, Seychelles is the only country on the continent where a national COVID-19 vaccination campaign has started. ....

Olaposi Omotuyi , Genomics Research Institute Of Afe Babalola University , Chemo Genomics Research Institute , Afe Babalola University , மரபியல் ஆராய்ச்சி நிறுவனம் ஆஃப் அபி பாபலோலா பல்கலைக்கழகம் , கீமோ மரபியல் ஆராய்ச்சி நிறுவனம் , அபி பாபலோலா பல்கலைக்கழகம் ,

ABUAD researchers to unveil herbal cure for COVID-19

ABUAD researchers to unveil herbal cure for COVID-19
ABUAD researchers to unveil herbal cure for COVID-19
Share
The Chemo-Genomics Research Institute of Afe Babalola University, Ado-Ekiti (ABUAD), in collaboration with the Multi-system Hospital, are on the verge of inventing herbal medicine for the cure of the ravaging COVID-19 disease.
The university’s researchers have also gained a new understanding about the reasons why humans are more vulnerable to infections by the new variant of COVID-19, popularly known as N501Y SARS-CoV-2 mutant.
A statement in Ado-Ekiti by ABUAD’s Public Relations Officer, Tunde Olofintila, on Thursday, said one of the reasons provided by the bio-medical scientists and Researchers, led by Dr Olaposi Omotuyi, is that the new variant is 80 times more effective at binding to human cells and is characterized by faster human-to-human transmission, more rapid progression of symptoms and death. ....

Tunde Olofintila , Olaposi Omotuyi , Genomics Research Institute Of Afe Babalola University , Nigeria Centre For Disease Control , Chemo Genomics Research Institute , Afe Babalola University , Multi System Hospital , Relations Officer , Tribune Online , Nigeria Centre , Disease Control , மரபியல் ஆராய்ச்சி நிறுவனம் ஆஃப் அபி பாபலோலா பல்கலைக்கழகம் , நைஜீரியா மையம் க்கு நோய் கட்டுப்பாடு , கீமோ மரபியல் ஆராய்ச்சி நிறுவனம் , அபி பாபலோலா பல்கலைக்கழகம் , பல அமைப்பு மருத்துவமனை , உறவுகள் அதிகாரி , ட்ரிப்யூன் நிகழ்நிலை , நைஜீரியா மையம் , நோய் கட்டுப்பாடு ,